<VariationArchive VariationID="590611" VariationName="NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs)" VariationType="Deletion" Accession="VCV000590611" Version="17" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-07-29" DateCreated="2018-11-20" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="581552" VariationID="590611">
      <GeneList>
        <Gene Symbol="LOC126862902" FullName="BRD4-independent group 4 enhancer GRCh37_chr19:38995830-38997029" GeneID="126862902" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="38505190" stop="38506389" display_start="38505190" display_stop="38506389" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="RYR1" FullName="ryanodine receptor 1" GeneID="6261" HGNC_ID="HGNC:10483" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="38433691" stop="38587564" display_start="38433691" display_stop="38587564" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="38924339" stop="39078203" display_start="38924339" display_stop="39078203" Strand="+" />
          </Location>
          <OMIM>180901</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR1">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs)</Name>
      <CanonicalSPDI>NC_000019.10:38505338:ATA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="38505339" stop="38505340" display_start="38505339" display_stop="38505340" variantLength="2" positionVCF="38505338" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="38995979" stop="38995980" display_start="38995979" display_stop="38995980" variantLength="2" positionVCF="38995978" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>NM_000540.3(RYR1):c.8342_8343del</Name>
        <Name>p.Ile2781fs</Name>
      </OtherNameList>
      <ProteinChange>I2781fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.38505340_38505341del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.38505340_38505341del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.38995980_38995981del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.38995980_38995981del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008866.1" sequenceAccession="NG_008866" sequenceVersion="1" change="g.76641_76642del">
            <Expression>NG_008866.1:g.76641_76642del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_087399.1" sequenceAccession="NG_087399" sequenceVersion="1" change="g.251_252del">
            <Expression>NG_087399.1:g.251_252del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000540.2" sequenceAccession="NM_000540" sequenceVersion="2" change="c.8342_8343delTA">
            <Expression>NM_000540.2:c.8342_8343delTA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000531.2" sequenceAccession="NP_000531" sequenceVersion="2" change="p.Ile2781Argfs">
            <Expression>NP_000531.2:p.Ile2781Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000540.3" sequenceAccession="NM_000540" sequenceVersion="3" change="c.8342_8343del" MANESelect="true">
            <Expression>NM_000540.3:c.8342_8343del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000531.2" sequenceAccession="NP_000531" sequenceVersion="2" change="p.Ile2781fs">
            <Expression>NP_000531.2:p.Ile2781fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042723.2" sequenceAccession="NM_001042723" sequenceVersion="2" change="c.8342_8343del">
            <Expression>NM_001042723.2:c.8342_8343del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001036188.1" sequenceAccession="NP_001036188" sequenceVersion="1" change="p.Ile2781fs">
            <Expression>NP_001036188.1:p.Ile2781fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_766" sequenceAccession="LRG_766">
            <Expression>LRG_766:g.76641_76642del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_766t1" sequenceAccession="LRG_766t1">
            <Expression>LRG_766t1:c.8342_8343del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_766p1" sequenceAccession="LRG_766p1" change="p.Ile2781fs">
            <Expression>LRG_766p1:p.Ile2781fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Interpreted" ID="2627379" DB="ClinVar" />
        <XRef Type="Allelic variant" ID="180901.0037" DB="OMIM" />
        <XRef Type="rs" ID="758580075" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs) AND not provided" Accession="RCV000721705" Version="11">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-04-29" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs) AND RYR1-related disorder" Accession="RCV001209505" Version="8">
        <ClassifiedConditionList TraitSetID="33623">
          <ClassifiedCondition DB="MedGen" ID="CN239331">RYR1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-25" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs) AND Congenital multicore myopathy with external ophthalmoplegia" Accession="RCV002535011" Version="4">
        <ClassifiedConditionList TraitSetID="3543">
          <ClassifiedCondition DB="MedGen" ID="C1850674">Congenital multicore myopathy with external ophthalmoplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-01-25" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs) AND multiple conditions" Accession="RCV002507269" Version="1">
        <ClassifiedConditionList TraitSetID="81991">
          <ClassifiedCondition DB="MedGen" ID="C0751951">Central core myopathy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1850674">Congenital multicore myopathy with external ophthalmoplegia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0546264">Congenital myopathy with fiber type disproportion</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1840365">King Denborough syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2930980">Malignant hyperthermia, susceptibility to, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs) AND Malignant hyperthermia, susceptibility to, 1" Accession="RCV003514405" Version="1">
        <ClassifiedConditionList TraitSetID="3539">
          <ClassifiedCondition DB="MedGen" ID="C2930980">Malignant hyperthermia, susceptibility to, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-30" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.8342_8343del (p.Ile2781fs) AND Centronuclear myopathy" Accession="RCV004586901" Version="1">
        <ClassifiedConditionList TraitSetID="8837">
          <ClassifiedCondition DB="MedGen" ID="C0175709">Centronuclear myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-01" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2018-11-20" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(9); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="DOI">10.1186/s13073-024-01353-0</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20839240</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21062345</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23919265</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25960145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28818389</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30611313</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(9); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33623" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36528" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RYR1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RYR1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RYR1-Related Disorders</ElementValue>
              </Name>
              <XRef ID="CN239331" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3539" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2639" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Anesthesia related hyperthermia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fulminating hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pharmacogenic myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperthermia suceptibility 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Malignant hyperthermia, susceptibility to, 1</ElementValue>
                <XRef ID="MONDO:0007783" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MHS1</ElementValue>
                <XRef Type="MIM" ID="145600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3363" />
                <XRef ID="3363" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeletal muscle hypermetabolism. Manifestations of malignant hyperthermia (MH) are precipitated by certain volatile anesthetics (i.e., halothane, isoflurane, sevoflurane, desflurane, enflurane), either alone or in conjunction with a depolarizing muscle relaxant (specifically, succinylcholine). The triggering substances cause uncontrolled release of calcium from the sarcoplasmic reticulum and may promote entry of extracellular calcium into the myoplasm, causing contracture of skeletal muscles, glycogenolysis, and increased cellular metabolism, resulting in production of heat and excess lactate. Affected individuals experience acidosis, hypercapnia, tachycardia, hyperthermia, muscle rigidity, compartment syndrome, rhabdomyolysis with subsequent increase in serum creatine kinase (CK) concentration, hyperkalemia with a risk for cardiac arrhythmia or even cardiac arrest, and myoglobinuria with a risk for renal failure. In nearly all cases, the first manifestations of MH (tachycardia and tachypnea) occur in the operating room; however, MH may also occur in the early postoperative period. There is mounting evidence that some individuals with MHS will also develop MH with exercise and/or on exposure to hot environments. Without proper and prompt treatment with dantrolene sodium, mortality is extremely high.</Attribute>
                <XRef ID="NBK1146" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Pharmacogenetic</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="EMHG, 2018">
                <ID Source="PubMed">33131754</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301325</ID>
                <ID Source="BookShelf">NBK1146</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3110041</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Sei et al., 2004">
                <ID Source="PubMed">14870754</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_MalignantHyperthermia-enPro649.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Malignant hyperthermia</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Malignant-Hyperthermia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, RYR1 and CACNA1S Pathogenic Variants (Malignant Hyperthermia), 2019</CitationText>
              </Citation>
              <XRef ID="423" DB="Orphanet" />
              <XRef ID="C2930980" DB="MedGen" />
              <XRef ID="MONDO:0007783" DB="MONDO" />
              <XRef Type="MIM" ID="145600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3543" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3205" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Multicore myopathy with external ophthalmoplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiminicore disease with external ophthalmoplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital myopathy 1B, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy</ElementValue>
                <XRef ID="HP:0003789" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="C150608" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTICORE MYOPATHY</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital multicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="MONDO:0009712" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO1B</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RYR1-Related Multiminicore Disease</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10316" />
                <XRef ID="10316" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22009146</ID>
              </Citation>
              <XRef ID="598" DB="Orphanet" />
              <XRef ID="98905" DB="Orphanet" />
              <XRef ID="C1850674" DB="MedGen" />
              <XRef ID="MONDO:0009712" DB="MONDO" />
              <XRef Type="MIM" ID="255320" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003789" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003804" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8837" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14948" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Centronuclear myopathy</ElementValue>
                <XRef ID="MONDO:0018947" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotubular myopathy</ElementValue>
                <XRef ID="82077006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Centronuclear myopathy, congenital</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CNM</ElementValue>
                <XRef ID="GTR000016534" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="101" />
                <XRef ID="101" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">All</Attribute>
                <XRef ID="GTR000016534" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="595" DB="Orphanet" />
              <XRef ID="C0175709" DB="MedGen" />
              <XRef ID="MONDO:0018947" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS160150" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81991" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="5593" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital Fiber-Type Disproportion</ElementValue>
                <XRef ID="NBK1259" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myopathy with fiber type disproportion</ElementValue>
                <XRef ID="Congenital+Fiber+Type+Disproportion/1827" DB="Genetic Alliance" />
                <XRef ID="240084007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital fiber-type disproportion myopathy</ElementValue>
                <XRef ID="MONDO:0009711" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CFTDM</ElementValue>
                <XRef Type="MIM" ID="255310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SELENON-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TPM3-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ACTA1-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6161" />
                <XRef ID="6161" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">all</Attribute>
                <XRef ID="GTR000276064" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="2020" DB="Orphanet" />
              <XRef ID="C0546264" DB="MedGen" />
              <XRef ID="MONDO:0009711" DB="MONDO" />
            </Trait>
            <Trait ID="2639" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Anesthesia related hyperthermia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fulminating hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pharmacogenic myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperthermia suceptibility 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Malignant hyperthermia, susceptibility to, 1</ElementValue>
                <XRef ID="MONDO:0007783" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MHS1</ElementValue>
                <XRef Type="MIM" ID="145600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3363" />
                <XRef ID="3363" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeletal muscle hypermetabolism. Manifestations of malignant hyperthermia (MH) are precipitated by certain volatile anesthetics (i.e., halothane, isoflurane, sevoflurane, desflurane, enflurane), either alone or in conjunction with a depolarizing muscle relaxant (specifically, succinylcholine). The triggering substances cause uncontrolled release of calcium from the sarcoplasmic reticulum and may promote entry of extracellular calcium into the myoplasm, causing contracture of skeletal muscles, glycogenolysis, and increased cellular metabolism, resulting in production of heat and excess lactate. Affected individuals experience acidosis, hypercapnia, tachycardia, hyperthermia, muscle rigidity, compartment syndrome, rhabdomyolysis with subsequent increase in serum creatine kinase (CK) concentration, hyperkalemia with a risk for cardiac arrhythmia or even cardiac arrest, and myoglobinuria with a risk for renal failure. In nearly all cases, the first manifestations of MH (tachycardia and tachypnea) occur in the operating room; however, MH may also occur in the early postoperative period. There is mounting evidence that some individuals with MHS will also develop MH with exercise and/or on exposure to hot environments. Without proper and prompt treatment with dantrolene sodium, mortality is extremely high.</Attribute>
                <XRef ID="NBK1146" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Pharmacogenetic</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="EMHG, 2018">
                <ID Source="PubMed">33131754</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301325</ID>
                <ID Source="BookShelf">NBK1146</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3110041</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Sei et al., 2004">
                <ID Source="PubMed">14870754</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_MalignantHyperthermia-enPro649.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Malignant hyperthermia</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Malignant-Hyperthermia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, RYR1 and CACNA1S Pathogenic Variants (Malignant Hyperthermia), 2019</CitationText>
              </Citation>
              <XRef ID="423" DB="Orphanet" />
              <XRef ID="C2930980" DB="MedGen" />
              <XRef ID="MONDO:0007783" DB="MONDO" />
              <XRef Type="MIM" ID="145600" DB="OMIM" />
            </Trait>
            <Trait ID="3205" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Multicore myopathy with external ophthalmoplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiminicore disease with external ophthalmoplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital myopathy 1B, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy</ElementValue>
                <XRef ID="HP:0003789" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="C150608" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTICORE MYOPATHY</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital multicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="MONDO:0009712" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO1B</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RYR1-Related Multiminicore Disease</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10316" />
                <XRef ID="10316" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22009146</ID>
              </Citation>
              <XRef ID="598" DB="Orphanet" />
              <XRef ID="98905" DB="Orphanet" />
              <XRef ID="C1850674" DB="MedGen" />
              <XRef ID="MONDO:0009712" DB="MONDO" />
              <XRef Type="MIM" ID="255320" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003789" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003804" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="865" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Central core myopathy</ElementValue>
                <XRef ID="MONDO:0007294" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Central core disease</ElementValue>
                <XRef ID="Central+Core+Disease/1190" DB="Genetic Alliance" />
                <XRef ID="43152001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Central core disease of muscle</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscle core disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular central core disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myopathy, central fibrillar</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Shy-Magee syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO1A</ElementValue>
                <XRef Type="MIM" ID="117000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CCO</ElementValue>
                <XRef Type="MIM" ID="117000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6014" />
                <XRef ID="6014" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Pharmacogenetic</Attribute>
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21989361</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22009146</ID>
              </Citation>
              <XRef ID="597" DB="Orphanet" />
              <XRef ID="C0751951" DB="MedGen" />
              <XRef ID="MONDO:0007294" DB="MONDO" />
              <XRef Type="MIM" ID="117000" DB="OMIM" />
            </Trait>
            <Trait ID="6212" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">King syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">King Denborough syndrome</ElementValue>
                <XRef ID="764957003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KDS</ElementValue>
                <XRef Type="MIM" ID="619542" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8433" />
                <XRef ID="8433" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1840365" DB="MedGen" />
              <XRef ID="MONDO:0020485" DB="MONDO" />
              <XRef Type="MIM" ID="619542" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1662504" SubmissionDate="2018-10-12" DateLastUpdated="2018-11-20" DateCreated="2018-11-20">
        <ClinVarSubmissionID localKey="NM_000540.2:c.8342_8343delTA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000852833" DateUpdated="2018-11-20" DateCreated="2018-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.2:c.8342_8343delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4498512</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5458882" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000540.3:c.8342_8343del|OMIM:117000;145600;255310;255320;619542" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002806695" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.3:c.8342_8343del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="117000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="145600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255310" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255320" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619542" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6450574" SubmissionDate="2023-01-27" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="e59e510d-65a7-40ac-8d4f-2bfb48c74832" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003761396" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Ile2781ArgfsTer49 variant in RYR1 was identified by our study, in the compound heterozygous state with a variant of uncertain significance (ClinVar Variation ID: 845794), in one individual with minicore myopathy with external ophthalmoplegia. Trio exome analysis revealed that this variant was in trans with a variant of uncertain significance (ClinVar Variation ID: 845794). The p.Ile2781ArgfsTer49 variant in RYR1 has been previously reported in 5 unrelated individuals with minicore myopathy with external ophthalmoplegia (PMID: 30872186, PMID: 20839240, PMID: 20839240), but has been identified in 0.02% (9/41444) of African/African American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs758580075). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. Of these 5 unrelated individuals, 2 were compound heterozygotes who carried pathogenic variants in trans (PMID: 21062345, PMID: 20839240, ClinVar Variation ID: 132994) and 2 were compound heterozygotes who carried pathogenic variants with unknown phase (PMID: 20839240, ClinVar Variation ID: 132994), which increases the likelihood that the p.Ile2781ArgfsTer49 is pathogenic. This variant has also been reported in ClinVar (Variation ID: 590611) and has been interpreted as pathogenic by multiple submitters. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 2781 and leads to a premature termination codon 49 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the RYR1 gene is an established disease mechanism of autosomal recessive minicore myopathy with external ophthalmoplegia. In summary, this variant meets criteria to be classified as pathogenic for minicore myopathy with external ophthalmoplegia. ACMG/AMP Criteria applied: PVS1, PM3_Strong (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000540.3(RYR1):c.8342_8343del</Name>
            <Name>p.Ile2781fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.10:g.38505340_38505341del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009712" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12627697</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2306603" SubmissionDate="2021-12-22" DateLastUpdated="2023-03-04" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDXSV:217867" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001168610" DateUpdated="2023-03-04" DateCreated="2020-03-16" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed in 5/23,590 (0.02%) alleles from individuals of African background, in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 21062345, 30611313, 27535533, 20839240, 30872186)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:742161</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.2:c.8342_8343del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_77_20211222054205</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7113407" SubmissionDate="2023-03-01" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="e5df32b47a410f6234c7bfbe1c9c7ad1" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003807308" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PVS1 very strong, PM2 moderated, PM3 supporting, PP1 supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <Description>Paired-end whole-genome sequencing</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.3:c.8342_8343del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255320" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12925816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7570096" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_000540.2:c.8342_8343del|RYR1-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046371" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 53 of 106 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a compound heterozygous change in patients with congenital myopathy with central nuclei (PMID: 21062345, 30611313, 20839240). The c.8342_8343del (p.Ile2781ArgfsTer49) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.002% (5/280914) and is absent in the homozygous state, thus is presumed to be rare. Based on the available evidence, the c.8342_8343del (p.Ile2781ArgfsTer49) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.2:c.8342_8343del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RYR1-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7125461" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="4fef1abc91b80afed0f3b0c6a55a0e9b24673d3b2076f35f3644a99165d13b75|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003827293" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.3:c.8342_8343del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2715726" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="2366631|MedGen:CN239331" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001380942" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23919265</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25960145</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28818389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30611313</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20839240</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21062345</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile2781Argfs*49) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RYR1 are known to be pathogenic (PMID: 23919265, 25960145, 28818389, 30611313). This variant is present in population databases (rs758580075, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with autosomal recessive congenital myopathy (PMID: 20839240, 21062345). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 590611). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.38995979_38995980del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN239331" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8045135" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkT1UcgJiO7RiQk98P_WGaZs|MedGen:C2930980" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004358151" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>This variant deletes 2 nucleotides in exon 53 of the RYR1 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with malignant hyperthermia susceptibility in the literature. This variant has been identified in 5/280914 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of RYR1 function due to haploinsufficiency is not an established disease mechanism for autosomal dominant malignant hyperthermia, although it is associated with other phenotype(s) (ClinVar Variation ID: 590611). Due to insufficient evidence, this variant is classified as a Variant of Uncertain Significance for autosomal dominant malignant hyperthermia.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.3:c.8342_8343del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2930980" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9248172" SubmissionDate="2024-04-16" DateLastUpdated="2024-07-15" DateCreated="2024-07-15">
        <ClinVarSubmissionID localKey="NM_000540.3:c.8342_8343del|Orphanet:ORPHA595" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005038476" DateUpdated="2024-07-15" DateCreated="2024-07-15" Type="SCV" Version="1" SubmitterName="Muscle and Diseases Team, Institut de Génétique et Biologie Moléculaire et Cellulaire" OrgID="509530" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="DOI">10.1186/s13073-024-01353-0</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20839240</ID>
          </Citation>
          <Comment>PVS1+PM2+PM3_Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.3:c.8342_8343del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA595" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="DOI">10.1186/s13073-024-01353-0</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB14382184</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5458882" TraitType="Disease" MappingType="XRef" MappingValue="619542" MappingRef="OMIM">
        <MedGen CUI="C1840365" Name="King Denborough syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7125461" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306603" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458882" TraitType="Disease" MappingType="XRef" MappingValue="255320" MappingRef="OMIM">
        <MedGen CUI="C1850674" Name="Congenital multicore myopathy with external ophthalmoplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2715726" TraitType="Disease" MappingType="XRef" MappingValue="CN239331" MappingRef="MedGen">
        <MedGen CUI="CN239331" Name="RYR1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1662504" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458882" TraitType="Disease" MappingType="XRef" MappingValue="255310" MappingRef="OMIM">
        <MedGen CUI="CN178536" Name="Congenital myopathy 4A, autosomal dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7113407" TraitType="Disease" MappingType="XRef" MappingValue="255320" MappingRef="OMIM">
        <MedGen CUI="C1850674" Name="Congenital multicore myopathy with external ophthalmoplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458882" TraitType="Disease" MappingType="XRef" MappingValue="117000" MappingRef="OMIM">
        <MedGen CUI="C0751951" Name="Central core myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8045135" TraitType="Disease" MappingType="XRef" MappingValue="C2930980" MappingRef="MedGen">
        <MedGen CUI="C2930980" Name="Malignant hyperthermia, susceptibility to, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6450574" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009712" MappingRef="MONDO">
        <MedGen CUI="C1850674" Name="Congenital multicore myopathy with external ophthalmoplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458882" TraitType="Disease" MappingType="XRef" MappingValue="145600" MappingRef="OMIM">
        <MedGen CUI="C2930980" Name="Malignant hyperthermia, susceptibility to, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9248172" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA595" MappingRef="Orphanet">
        <MedGen CUI="C0175709" Name="Centronuclear myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7570096" TraitType="Disease" MappingType="Name" MappingValue="RYR1-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN239331" Name="RYR1-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

